Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

16 resultsUpdated October 23, 2026
2

Effectiveness of generic direct-acting agents for the treatment of hepatitis C: systematic review and meta-analysis

Bulletin of the World Health Organization 98(3) (2019)

Hugo Perazzo; Rodolfo Castro; Paula M. Luz; Mariana Banholi; Rafaela Valentim Goldenzon; Sandra Wagner Cardoso; Beatriz Gilda Jegerhorn Grinsztejn; Valdilea Gonçalves Veloso

3

Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting

Journal of Clinical Virology 113 (2019)

Heidar Sharafi; Hossein Poustchi; Fatemeh Azimian Zavareh; Babak Tamadoni; Rashid Ramezani; Mohamad Mehdi Gouya; Mahdi Sheikh; Farnaz Hashemi; Mehrzad Tashakorian; Ramin Alasvand; Seyed Moayed Alavian; Shahin Merat

4

Update on Recommendations for the Clinical Management of Hepatitis C in Iran 2017

Hepatitis Monthly 17(11) (2017)

Seyed Moayed Alavian; Heidar Sharafi

5

Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study

BMJ Open 12(6) (2022)

Mohammad Tasavon Gholamhoseini; Heidar Sharafi; Helena Hiemisch Lobo Borba; Seyed Moayed Alavian; Asma Sabermahani; Behzad Hajarizadeh

6

Hepatitis C virus infection in Iran: A review of current prevalence and preventive strategies from a developing country

Journal of Clinical Virology Plus 4(3) (2024)

Marcarious Moorkereh Tantuoyir; Muhammed M. Camara; Marjan Sohrabi; SeyedAhmad SeyedAlinaghi; Zahra Ahmadinejad

7

A simple risk-based strategy for hepatitis C virus screening among incarcerated people in a low- to middle-income setting

Harm Reduction Journal 17(1) (2020)

Sanam Hariri; Maryam Sharafkhah; Maryam Alavi; Gholamreza Roshandel; Abdolreza Fazel; Taghi Amiriani; Nazgol Motamed-Gorji; Abolfazl Bazazan; Shahin Merat; Hossein Poustchi; Reza Malekzadeh

8

Seroprevalence of Hepatitis C Virus among Blood Donors in Middle Eastern Countries: A Systematic Review and Meta-Analysis

Iranian Red Crescent Medical Journal 19(12) (2017)

Hossein Ghaderi-Zefrehi; Heidar Sharafi; Farzin Sadeghi; Mohammad Gholami Fesharaki; Alireza Farasat; Fatemeh Jahanpeyma; Seyed Moayed Alavian

10

Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders

Virology Journal 18(1) (2021)

Heidar Sharafi; Bita Behnava; Alireza Azizi-saraji; Ali Namvar; Ali Anvar; Shima Salimi; Seyed Moayed Alavian

12

Treatment of HCV Infection with Direct-Acting Antiviral Agents in Patients with HIV/HCV Co-Infection: A Systematic Review

Hepatitis Monthly In Press(In Press) (2018)

Saman Mohazzab Torabi; Fardin Dolatimehr; Heidar Sharafi; Mahdi Safiabadi; Mohammad Saeid Rezaee Zavareh; Ehsan Bayatpour; Hamidreza Karimi‐Sari; Seyed Moayed Alavian

13

Pooled Prevalence of NS5A Resistance-Associated Substitutions in Chronic HCV Genotype 3 Infection: A Study Based on Deposited Sequences in GenBank

Microbial Drug Resistance 25(7) (2019)

Heidar Sharafi; Saman Ghalamkari; Alireza Hassanshahi; Seyed Moayed Alavian

14

Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?

World Journal of Hepatology 10(9) (2018)

Heidar Sharafi; Seyed Moayed Alavian

16

Effects of sofosbuvir-based therapy on the metabolic status of patients with chronic hepatitis C infection

Trends in Medicine 19(6) (2019)

Ahmad Hezarjaribi; Mitra Ranjbar; Sayed Moayed Alavian; Sohrab Aghabeigi